ERBB2 and prostate carcinoma: The physiologic significance of ErbB2 in CRPC is supported by studies showing increased ErbB2 expression or activity in CRPC clinical samples, although this is not a consistent finding, and increased ErbB2 has also been associated with more aggressive primary untreated prostate cancer.